MMMzwandile Mbele

Mzwandile Mbele

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mzwandile Mbele has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ultrasound-boosted low-detergent decellularization yields biocompatible skin scaffolds with native ECM integrity

    by Sbonelo Khanyile, Mzwandile Mbele, Nonhlanhla P. Khumalo, Ardeshir Bayat

    Xenogeneic scaffolds derived from porcine skin offer a promising alternative due to their structural and biochemical similarities to human skin. However, current decellularization strategies compromise extracellular matrix (ECM) integrity, porosity, or mechanical performance, limiting applicability. Here, we developed a decellularized porcine matrix (DEPOMA) scaffold using an ultrasound-assisted low-detergent strategy designed to achieve effective cellular removal while preserving ECM architecture. Specifically, we focused on combining ultrasonication, hypertonic/hypotonic treatments, and reduced Triton X-100 exposure. Our protocol effectively removed cellular components with over 99% deoxyribonucleic acid (DNA) removal, while preserving key basement membrane and dermal proteins, as seen by quantitative immunohistochemistry (IHC) demonstrating 76% Laminin, approximately 66% Collagen IV, and 889% Elastin retention relative to native tissue. Scanning electron microscopy (SEM) demostrated that DEPOMA maintained native dermal ultrastructure with enhanced and uniformly distributed porosity, quantified using DIGIMIZER image analysis. Uniaxial tensile testing on DEPOMA demonstrated preserved mechanical properties comparable to native skin. The DEPOMA scaffold demonstrated markedly enhanced biocompatibility, supporting a 3.4-fold increase in primary human fibroblast metabolic activity compared to controls. In a porcine full-thickness ex vivo wound model, DEPOMA showed progressive host-derived cellular infiltration reaching a penetration depth of 147 µm after 21 days, consistent with active scaffold integration and remodeling. When benchmarked against a detergent-based decellularized scaffold and a commercial dermal regeneration template, DEPOMA exhibited significantly improved cell viability and proliferative capacity. Collectively, these findings demonstrate that ultrasound-assisted low-detergent decellularization enables superior ECM preservation, structural integrity, and biological performance, supporting DEPOMA as a translationally optimized dermal scaffold for wound healing and regenerative medicine applications.

  • Open Access

    African Medicinal Plants in Cutaneous Wound Repair: A Comprehensive Analysis of the Role of Phytochemicals

    by Philisiwe F. Molefe, Zeinab Ghasemishahrestani, Mzwandile Mbele, Sbonelo Khanyile, Jill Farrant, Nonhlanhla P. Khumalo, Ardeshir Bayat

    Chronic and non‐healing wounds are a global health issue with limited effective treatments. Wound care costs continue to rise, highlighting the need for new therapies. Medicinal plants, particularly African species, show promise for enhancing wound healing. This review analysed 93 studies and identified 37 relevant to wound healing, covering 39 plant species. Ten species were identified for their rich phytochemical content, specifically flavonoids, terpenoids, and alkaloids (plant‐derived compounds). These compounds act synergistically, enhancing the wound healing process at each stage. Flavonoids reduce inflammation and support tissue turnover, while terpenoids enhance collagen production and wound closure. Alkaloids offer antimicrobial benefits and support wound contraction. Notable plants include Ageratum conyzoides and Aspilia africana (Asteraceae family); promoting haemostasis by lowering plasma fibrinogen and enhancing platelet‐derived growth factors; Withania somnifera (Solanaceae); and Entada africana (Fabaceae), effectively regulating inflammation. In the proliferative phase, Ocimum gratissimum (Lamiaceae), Calendula officinalis (Asteraceae), and Centella asiatica (Apiaceae) although C. officinalis is native to Southern Europe, and C. asiatica an Asian‐native; they are widely used in African traditional medicine and included here for their relevance in African wound healing practices; Justicia flava (Acanthaceae), Alternanthera sessilis (Amaranthaceae), and Acalypha indica (Euphorbiaceae); play key roles in enhancing collagen production, angiogenesis, and re‐epithelialisation. This comprehensive analysis highlights the role of African medicinal plants in wound healing and their potential to improve wound care therapy.


  • Open Access

    A multinational review: Oesophageal cancer in low to middle‑income countries (Review)

    by Rodney Hull, Mzwandile Mbele, Tshepiso Makhafola, Chindo Hicks, Shao Ming Wang, Rui Manuel Reis, Ravi Mehrotra, Zilungile Mkhize‑Kwitshana, Showket Hussain, Gibson Kibiki, et al.

    Oesophageal cancer (OC) is an aggressive neoplasm that manifests in the gastrointestinal tract and is the result of numerous factors that can contribute to the development of the disease. These may include old age, nutritional deficiencies, oesophageal obstruction and food ingestion difficulties. Environmental factors serve a large role in increasing the risk of developing OC. Two factors that serve an increasing risk of developing OC are the use of tobacco and the consumption of alcohol. Genetic factors also exhibit a large effect on the risk of developing OC, for example, the causative genes in Black Africans differ from other races. OC is 3‑4 times more common among men than women. OC has been previously reported in >450 000 individuals worldwide, and its incidence is increasing. The current review compares OC in low to middle‑income countries with developed countries. The incidence of OC, particularly squamous cell carcinoma (SCC) is high in low and middle‑income countries. In developed countries, the incidence of SCC is low compared with adenocarcinoma. The majority of OC cases are diagnosed in the late stages of the disease, leading to high mortality rates. The current review aimed to discuss factors that contribute to the development of this disease in different geographical areas and genetic mechanisms governing these findings. The current review also aims to discuss the preventative treatment options for the disease, and also discusses the diagnosis and surveillance in five LMICs, including South Africa, China, Tanzania, India and Brazil.